Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10784815
United States Court of Appeals for the Ninth Circuit
United States v. Centeno
No. 10784815 · Decided February 5, 2026
No. 10784815·Ninth Circuit · 2026·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
February 5, 2026
Citation
No. 10784815
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION FILED
UNITED STATES COURT OF APPEALS FEB 5 2026
MOLLY C. DWYER, CLERK
U.S. COURT OF APPEALS
FOR THE NINTH CIRCUIT
UNITED STATES OF AMERICA, No. 23-3279
D.C. No.
Plaintiff - Appellee, 3:22-cr-02864-H-1
v.
MEMORANDUM*
JAIME CENTENO,
Defendant - Appellant.
UNITED STATES OF AMERICA, No. 23-3282
Plaintiff - Appellee, D.C. No.
3:17-cr-03258-H-1
v.
JAIME CENTENO,
Defendant - Appellant.
Appeal from the United States District Court
for the Southern District of California
Marilyn L. Huff, District Judge, Presiding
Argued and Submitted November 18, 2025
Pasadena, California
*
This disposition is not appropriate for publication and is not precedent
except as provided by Ninth Circuit Rule 36-3.
Before: WARDLAW and MILLER Circuit Judges.**
Jaime Centeno appeals his conviction for attempted reentry after deportation
in violation of 8 U.S.C. § 1326. He argues that the district court improperly
conducted the required three-step procedure under Batson v. Kentucky, 476 U.S.
79, 96–98 (1986), and that the district court abused its discretion by excluding any
mention of the prescription medication Olanzapine. We have jurisdiction under 28
U.S.C. § 1291, and we affirm.
1. Our review of the record indicates that Centeno failed to meet his burden
of proving purposeful discrimination at Batson step three. Batson details a three-
step burden-shifting process that trial courts must use when evaluating a
defendant’s allegation that a prosecutor struck potential jurors on the basis of
gender:
First, a defendant must make a prima facie showing that a
peremptory challenge has been exercised on the basis of
[gender]. Second, if that showing has been made, the
prosecution must offer a [gender]-neutral basis for striking
the juror in question. Third, in light of the parties’
submissions, the trial court must determine whether the
defendant has shown purposeful discrimination.
United States v. Alanis, 335 F.3d 965, 967 (9th Cir. 2003) (alterations in original)
(quoting Miller-El v. Cockrell, 537 U.S. 322, 328–29 (2003)); see also J.E.B. v.
**
Judge Sandra S. Ikuta, who died on December 7, 2025, was originally a member
of this panel. Judge Wardlaw and Judge Miller decided the appeal as a two-judge
quorum. See 28 U.S.C. § 46(d); 9th Cir. Gen. Ord. 3.2(h).
2 23-3279
Alabama ex rel. T.B., 511 U.S. 127, 130–31 (1994). Although we ordinarily will
not set aside a district court’s findings under Batson unless clearly erroneous, we
“have applied de novo review . . . where the court improperly applied” the Batson
framework. United States v. Mikhel, 889 F.3d 1003, 1028 (9th Cir. 2018). We
assume that Centeno met his burden of establishing a prima facie case at step one
because the prosecution offered gender-neutral reasons for each challenged strike,
thereby mooting Centeno’s requirement to put forth a prima facie case. See
Hernandez v. New York, 500 U.S. 352, 359 (1991) (“Where the defendant has done
everything that would be required of him if the plaintiff had properly made out a
prima facie case, whether the plaintiff really did so is no longer relevant.” (quoting
U.S. Postal Serv. Bd. of Governors v. Aikens, 460 U.S. 711, 715 (1983))).
Accordingly, we also assume that the district court erred in failing to conduct the
Batson step three analysis, which requires “a sensitive inquiry into such
circumstantial and direct evidence of intent as may be available” and “a clear
record that the trial court made a deliberate decision on the ultimate question of
purposeful discrimination.” Alanis, 335 F.3d at 968 n.2 (quotation marks and
citation omitted).
However, upon de novo review of the record, see United States v. Alvarez-
Ulloa, 784 F.3d 558, 565–66 (9th Cir. 2015), we conclude that no purposeful
discrimination was shown. The government used peremptory strikes on four
3 23-3279
female jurors and two male jurors. While such strikes reflect a statistical disparity
between females and males, that disparity is not large, especially given the small
size of the sample. The seated jury consisted of eight females (out of twelve) and
one female alternate (out of two). Moreover, the government offered a persuasive,
gender-neutral reason for exercising a peremptory strike for each of the four
challenged female jurors, and Centeno has failed to point to any other
circumstances that would suggest those reasons were pretextual.
2. The district court erred in excluding any mention of Olanzapine, but we
conclude the error was harmless beyond a reasonable doubt. Under Federal Rule
of Evidence 403, evidence may be excluded if “its probative value is substantially
outweighed by a danger of . . . unfair prejudice.” But, “the exclusion of evidence
offered by the defendant in a criminal prosecution under Rule 403 is ‘an
extraordinary remedy to be used sparingly.’” United States v. Haischer, 780 F.3d
1277, 1281 (9th Cir. 2015) (quoting United States v. Mende, 43 F.3d 1298, 1302
(9th Cir. 1995)). Here, the risk of prejudice was minimal because Centeno was not
planning to offer any diagnoses or information about the drug’s purpose. The
name of the medication is not so inflammatory that the risk of unfair prejudice
substantially outweighed its probative value, and any lingering prejudice could
have been cured with a limiting instruction. Moreover, the evidence was
probative: Centeno’s only defense at trial was that he did not have the required
4 23-3279
specific intent for attempted reentry because he intended to be arrested upon entry.
Evidence that he had been prescribed a specific prescription medication while in
federal custody in the past and desired a prescription for that medication again was
probative as to whether he crossed the border with the intent of being arrested.
While the exclusion of any reference to Olanzapine hindered Centeno’s
ability to present a complete defense, the government has established that the
exclusion of that evidence was harmless beyond a reasonable doubt. “[T]he
Constitution guarantees criminal defendants ‘a meaningful opportunity to present a
complete defense.’” United States v. Stever, 603 F.3d 747, 755 (9th Cir. 2010)
(quoting Holmes v. South Carolina, 547 U.S. 319, 324 (2006)). “[W]hen evidence
is excluded on the basis of an improper application of the evidentiary rules, the
danger of a due process violation is particularly great, since the exclusion [of the
evidence] is unsupported by any legitimate . . . justification.” United States v.
Evans, 728 F.3d 953, 959–60 (9th Cir. 2013) (alterations in original) (internal
quotation marks and citations omitted). If a constitutional violation is present, “we
must reverse the conviction unless we conclude that the error was harmless beyond
a reasonable doubt.” Haischer, 780 F.3d at 1281.
Here, Centeno was unable to present a complete defense because he could
not argue that he entered the United States specifically to obtain Olanzapine. But
even if Centeno had been able to show that he had previously been prescribed
5 23-3279
Olanzapine in detention, he had “Olanzapine” written down in the address book he
was arrested with, and he was subsequently prescribed Olanzapine in custody, it
nevertheless remains “clear beyond a reasonable doubt that the jury would have
returned a verdict of guilty.” United States v. Velarde-Gomez, 269 F.3d 1023, 1034
(9th Cir. 2001) (en banc)). The government presented persuasive evidence of
Centeno’s true motive: Centeno lied when he arrived at the San Ysidro Port of
Entry, telling a Customs and Border Protection officer, “I’m American.” Centeno
also handed the officer a copy of his California identification card. This evidence
overwhelmingly indicates that Centeno did not intend to enter the United States to
be arrested but instead intended to proceed through the border screening to roam
free from official restraint. Therefore, the inclusion of the Olanzapine evidence
would not have altered the jury’s guilty verdict.
AFFIRMED.1
1
Centeno’s Motion to extend time to file reply brief is granted. Dkt. No. 37.
6 23-3279
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS FEB 5 2026 MOLLY C.
Key Points
01NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS FEB 5 2026 MOLLY C.
02COURT OF APPEALS FOR THE NINTH CIRCUIT UNITED STATES OF AMERICA, No.
03Huff, District Judge, Presiding Argued and Submitted November 18, 2025 Pasadena, California * This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.
04Before: WARDLAW and MILLER Circuit Judges.** Jaime Centeno appeals his conviction for attempted reentry after deportation in violation of 8 U.S.C.
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS FEB 5 2026 MOLLY C.
FlawCheck shows no negative treatment for United States v. Centeno in the current circuit citation data.
This case was decided on February 5, 2026.
Use the citation No. 10784815 and verify it against the official reporter before filing.